W.l.gore & Associates
Clinical trials sponsored by W.l.gore & Associates, explained in plain language.
-
Real-World test of aortic Stent-Graft aims to confirm safety and training
Disease control ENROLLING_BY_INVITATIONThis study follows 300 people who receive the GORE TAMBE device, a stent-graft for complex aneurysms in the abdomen and chest. Researchers want to see if the device works well in real-world settings and if the training program for doctors is adequate. Participants are tracked for…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 23, 2026 12:01 UTC
-
New stent aims to fix aortic aneurysms without open surgery
Disease control OngoingThis study is testing a new stent device called the GORE® TAG® Thoracic Branch Endoprosthesis to treat aneurysms or lesions in the aortic arch and upper part of the main artery from the heart. About 250 participants will receive the device to see if it is safe and effective. The …
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
New stent aims to open blocked veins and heal leg ulcers
Disease control OngoingThis trial is testing a new stent (a small mesh tube) to treat blockages in the large vein in the abdomen (inferior vena cava) and nearby leg veins. The study involves 136 adults with symptoms like leg ulcers, pain, or swelling. Doctors will place the stent to keep the vein open …
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
Hernia mesh under the microscope: 5-Year study launched
Disease control OngoingThis study follows 320 people who had ventral or incisional hernia repair using GORE SYNECOR biomaterial. Researchers will track hernia recurrence, infections, and other complications over 5 years. The goal is to see how well the mesh performs in the long run for different patien…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 23, 2026 11:54 UTC
-
Heart-Device study aims to stop strokes in patients with a hole in the heart
Disease control OngoingThis study is checking how well a device called the GORE® CARDIOFORM Septal Occluder works and how safe it is for people who have had a stroke caused by a hole in the heart (PFO). Researchers will follow 300 patients in Japan for 12 months after the device is implanted. The goal …
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
New stent graft could fix Life-Threatening aorta tears without open surgery
Disease control ENROLLING_BY_INVITATIONThis study tests a special tube called a stent graft to repair damage in the upper part of the main artery from the heart (the ascending aorta). It is for people with bulges (aneurysms), tears (dissections), or other lesions that usually need open-heart surgery. The goal is to se…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC
-
New stent graft offers hope for complex aortic aneurysm patients
Disease control APPROVED_FOR_MARKETINGThis study provides expanded access to a stent graft device for people with thoracoabdominal or pararenal aortic aneurysms. Participants must have an aneurysm at least 5 cm wide, a saccular aneurysm, or one growing rapidly. The device is placed inside the aorta to reinforce the v…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 17, 2026 12:09 UTC
-
New stent aims to fix deadly aortic bulges without open surgery
Disease control OngoingThis study tests a new stent device (GORE EXCLUDER TAMBE) to treat thoracoabdominal and pararenal aortic aneurysms—dangerous bulges in the main artery. About 102 to 202 participants will receive the stent via a minimally invasive procedure. The goal is to see if the device can sa…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New implant offers hope for glaucoma patients failing drops
Disease control OngoingThis early study tests a new device called the GORE Glaucoma Drainage Implant in 30 adults with primary open-angle glaucoma that eye drops cannot control or who are at high risk of scarring from standard surgery. The goal is to see if the implant safely lowers eye pressure by at …
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New heart valve device offers hope for patients with congenital defects
Disease control OngoingThis study is testing a new device called the GORE PV1 to replace the pulmonary valve and rebuild the right ventricular outflow tract in people with congenital heart defects. The device is designed to improve blood flow from the heart to the lungs. The study includes 15 participa…
Phase: NA • Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 02, 2026 11:39 UTC
-
New registry tracks Stent-Graft device in Real-World use
Knowledge-focused OngoingThis registry is collecting information on how a special stent-graft device (GORE VIABAHN with PROPATEN surface) performs in everyday medical practice. It includes about 614 people with conditions like peripheral artery disease, aneurysms, or dialysis access problems. The goal is…
Sponsor: W.L.Gore & Associates • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:58 UTC
-
Massive global study monitors aortic stent safety in 4,600 patients
Knowledge-focused OngoingThis study is a large registry that collects real-world information on how well Gore aortic stent grafts work and what complications may occur. It follows about 4,600 people who need a minimally invasive repair of an aortic aneurysm or other aortic condition. The goal is to track…
Sponsor: W.L.Gore & Associates • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:49 UTC
-
New registry monitors VBX stent graft in Real-World use
Knowledge-focused OngoingThis study is a registry that collects safety and performance data on the GORE® VIABAHN® VBX Stent Graft when used in peripheral vessels. It involves 280 adults who need this device to treat peripheral vascular disease. The goal is to see how well the stent graft works and if the…
Sponsor: W.L.Gore & Associates • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC